The Patent Finder

R-Pharm US Operating LLC

Also on record
Records under this name other than the patents R-Pharm US Operating LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to R-Pharm US Operating LLC

PatentTitleStatus Expires Confidence
US 8,871,227Process and formulation containing epothilones and analogs thereof
Term ended
Term ended Dec 28, 2025 · From the USPTO record
Term endedTerm ended Dec 28, 2025From the USPTO record
US 7,932,031Methods for determining sensitivity to microtubule-stabilizing agents comprising ixabepilone by measuring the level of estrogen receptor 1
Term ended
Term ended Nov 29, 2025 · From the USPTO record
Term endedTerm ended Nov 29, 2025From the USPTO record
US 7,767,432Methods for the preparation, isolation and purification of epothilone B, and x-ray crystal structures of epothilone B
Term ended
Term ended Mar 21, 2025 · From the USPTO record
Term endedTerm ended Mar 21, 2025From the USPTO record
US 8,598,215Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
Term ended
Term ended Mar 15, 2025 · From the USPTO record
Term endedTerm ended Mar 15, 2025From the USPTO record
US 7,312,237Combination of Epothilone Analogs and Chemotherapeutic Agents for the Treatment of Proliferative Diseases
Term ended
Term ended Aug 21, 2024 · High confidence
Term endedTerm ended Aug 21, 2024High confidence
US 7,241,899Methods for the Preparation, Isolation and Purification of Epothilone B, and X-Ray Crystal Structures of Epothilone B
Term ended
Term ended Jul 26, 2024 · High confidence
Term endedTerm ended Jul 26, 2024High confidence
US RE42,191Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B
Term ended
Term ended Sep 22, 2023 · From the USPTO record
Term endedTerm ended Sep 22, 2023From the USPTO record
US 7,022,330Parenteral Formulation for Epothilone Analogs
Term ended
Ended no later than Jun 13, 2022 · Medium confidence
Term endedEnded no later than Jun 13, 2022Medium confidence
US RE41,393Treatment of refractory tumors using epothilone derivatives
Term ended
Term ended Feb 8, 2022 · From the USPTO record
Term endedTerm ended Feb 8, 2022From the USPTO record
US RE40,387Pharmaceutical Compositions, Dosage Forms and Methods for Oral Administration of Epothilones
Term ended
Term ended Jan 25, 2022 · Low confidence
Term endedTerm ended Jan 25, 2022Low confidence
10 of 31 patents shown.
Pro members see all 31.
Pro members: see all 31 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited